Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Standard of Care Lifestyle Support for Stage III NSCLC Cancer Patients

NCT05287971 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05287971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Standard of Care Lifestyle Support for Stage III NSCLC Cancer Patients
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Withdrawn
Start date
August 1, 2023
Completion date
May 1, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer